Cargando…

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

BACKGROUND: Tumor metastasis is one of the leading reasons of the dismal prognosis of hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is closely associated with tumor metastasis including HCC. The purpose of this study is to construct and validate an EMT-related gene signatur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Gongmin, Xia, Hongwei, Tang, Qiulin, Bi, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953549/ https://www.ncbi.nlm.nih.gov/pubmed/33712026 http://dx.doi.org/10.1186/s12935-021-01864-5

Ejemplares similares

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2021)

Correlations between chromobox homolog 8 and key factors of epithelial–mesenchymal transition in hepatocellular carcinoma
por: Zhu, Xiaonian, et al.
Publicado: (2019)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

MicroRNA-10b regulates epithelial–mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma
por: Hujie, Gulibaha, et al.
Publicado: (2018)

TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2018)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial–mesenchymal transition in hepatocellular carcinoma
por: Li, Jieqiong, et al.
Publicado: (2020)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial–mesenchymal transition of hepatocellular carcinoma
por: Li, Lei, et al.
Publicado: (2018)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
por: Ji, Huanhuan, et al.
Publicado: (2020)

Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma
por: Tan, Jia-Jie, et al.
Publicado: (2019)

Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition
por: Bao, Ying, et al.
Publicado: (2015)

Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model
por: Suzuki, Atsuko, et al.
Publicado: (2014)

Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells
por: Singla, Mamta, et al.
Publicado: (2018)

B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
por: Kang, Fu-biao, et al.
Publicado: (2015)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
por: Liu, Xian, et al.
Publicado: (2021)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial–mesenchymal transition and cell cycle arrest
por: Li, Lingling, et al.
Publicado: (2022)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression
por: Shen, Erdong, et al.
Publicado: (2020)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway
por: Zhang, Rui, et al.
Publicado: (2020)

Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
por: Ai, Jun, et al.
Publicado: (2023)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
por: Hu, Yang, et al.
Publicado: (2017)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b63qm02a7eo6rl104gk1ese03g